secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quantum Cyber N.V. (QUCY)
CIK:        0001874252
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001213900-26-034103
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Mainz Biomed receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Sep 16, 2026
--------------------------------------------------------------------------------

- Nasdaq notified Mainz Biomed on Mar 20, 2026 that its share price closed below $1.00 for 30 consecutive business days through Mar 19, 2026.
- Company has 180 calendar days, until Sep 16, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
- If not cured by Sep 16, 2026, Mainz may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.
- There can be no assurance of regaining compliance or avoiding delisting; the letter has no immediate impact on trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1874252/000121390026034103/0001213900-26-034103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1874252/000121390026034103/ea0283153-8k_mainz.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-034103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer